These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 1668115)

  • 1. Bioactions of 5-hydroxyicosatetraenoate and its interaction with platelet-activating factor.
    Rossi AG; O'Flaherty JT
    Lipids; 1991 Dec; 26(12):1184-8. PubMed ID: 1668115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-hydroxyicosatetraenoate stimulates neutrophils by a stereospecific, G protein-linked mechanism.
    O'Flaherty JT; Rossi AG
    J Biol Chem; 1993 Jul; 268(20):14708-14. PubMed ID: 8392058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutrophil degranulation: evidence pertaining to its mediation by the combined effects of leukotriene B4, platelet-activating factor, and 5-HETE.
    O'Flaherty JT
    J Cell Physiol; 1985 Feb; 122(2):229-39. PubMed ID: 2981891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of platelet-activating factor-induced lipid body formation: requisite roles for 5-lipoxygenase and de novo protein synthesis in the compartmentalization of neutrophil lipids.
    Bozza PT; Payne JL; Goulet JL; Weller PF
    J Exp Med; 1996 Apr; 183(4):1515-25. PubMed ID: 8666909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism involved in the mobilization of neutrophil calcium by 5-hydroxyeicosatetraenoate.
    O'Flaherty JT; Jacobson D; Redman J
    J Immunol; 1988 Jun; 140(12):4323-8. PubMed ID: 2836511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereospecific bioactions of 5-hydroxyeicosatetraenoate.
    Rossi AG; Thomas MJ; O'Flaherty JT
    FEBS Lett; 1988 Nov; 240(1-2):163-6. PubMed ID: 3191990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 15-Hydroxyeicosatetraenoic acid inhibits neutrophil migration across cytokine-activated endothelium.
    Takata S; Papayianni A; Matsubara M; Jimenez W; Pronovost PH; Brady HR
    Am J Pathol; 1994 Sep; 145(3):541-9. PubMed ID: 8080039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arachidonate metabolites, platelet-activating factor, and the mobilization of protein kinase C in human polymorphonuclear neutrophils.
    O'Flaherty JT; Nishihira J
    J Immunol; 1987 Mar; 138(6):1889-95. PubMed ID: 3029224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of human neutrophil responses to platelet activating factor by 5(S)-hydroxy-eicosatetraenoate.
    Rossi AG; Redman JF; Jacobson DP; O'Flaherty JT
    J Lipid Mediat; 1991; 4(2):165-74. PubMed ID: 1659464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced esterification process of 5-hydroxyeicosatetraenoic acid (5-HETE) in PMN from asthmatic patients.
    Radeau T; Godard P; Chavis C; Crastes de Paulet A; Damon M
    Prostaglandins; 1992 Jun; 43(6):583-94. PubMed ID: 1410523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of platelet-activating-factor receptors and the desensitization response in polymorphonuclear neutrophils.
    O'Flaherty JT; Jacobson DP; Redman JF
    Biochem J; 1992 Nov; 288 ( Pt 1)(Pt 1):241-8. PubMed ID: 1332696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet-activating factor (PAF) enhances tumor necrosis factor production by alveolar macrophages. Prevention by PAF receptor antagonists and lipoxygenase inhibitors.
    Dubois C; Bissonnette E; Rola-Pleszczynski M
    J Immunol; 1989 Aug; 143(3):964-70. PubMed ID: 2545780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutrophil degranulation responses to combinations of arachidonate metabolites and platelet-activating factor.
    O'Flaherty JT; Wykle RL; Thomas MJ; McCall CE
    Res Commun Chem Pathol Pharmacol; 1984 Jan; 43(1):3-23. PubMed ID: 6322256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of arachidonic acid liberation in platelet-activating factor-stimulated human polymorphonuclear neutrophils.
    Nakashima S; Suganuma A; Sato M; Tohmatsu T; Nozawa Y
    J Immunol; 1989 Aug; 143(4):1295-302. PubMed ID: 2545786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism of 5-hydroxyicosatetraenoate by human neutrophils: production of a novel omega-oxidized derivative.
    O'Flaherty JT; Wykle RL; Redman J; Samuel M; Thomas M
    J Immunol; 1986 Nov; 137(10):3277-83. PubMed ID: 3095426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transmembrane signaling in human polymorphonuclear neutrophils: 15(S)-hydroxy-(5Z,8Z,11Z,13E)-eicosatetraenoic acid modulates receptor agonist-triggered cell activation.
    Smith RJ; Justen JM; Nidy EG; Sam LM; Bleasdale JE
    Proc Natl Acad Sci U S A; 1993 Aug; 90(15):7270-4. PubMed ID: 8394015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of 1-O-alkyl-, 1-O-alk-1'-enyl-, and 1-O-acyl-2-acetyl-sn-glycero-3-phosphoethanolamines and -3-phosphocholines as agonists of the platelet-activating factor family.
    O'Flaherty JT; Tessner T; Greene D; Redman JR; Wykle RL
    Biochim Biophys Acta; 1994 Jan; 1210(2):209-16. PubMed ID: 8280772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism and regulation of neutrophil priming by platelet-activating factor.
    Gay JC
    J Cell Physiol; 1993 Jul; 156(1):189-97. PubMed ID: 8391006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet-activating factor stimulates multiple signaling pathways in cultured rat mesangial cells.
    Kester M; Thomas CP; Wang J; Dunn MJ
    J Cell Physiol; 1992 Nov; 153(2):244-55. PubMed ID: 1331121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet-activating factor (PAF) receptor-mediated calcium mobilization and phosphoinositide turnover in neurohybrid NG108-15 cells: studies with BN50739, a new PAF antagonist.
    Yue TL; Gleason MM; Gu JL; Lysko PG; Hallenbeck J; Feuerstein G
    J Pharmacol Exp Ther; 1991 Apr; 257(1):374-81. PubMed ID: 1850473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.